China Healthwise Holdings (HKSE:00348) YoY EBITDA Growth : -166.67% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. China Healthwise Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -166.67%.

China Healthwise Holdings's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.13.

China Healthwise Holdings YoY EBITDA Growth Historical Data

The historical data trend for China Healthwise Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings YoY EBITDA Growth Chart

China Healthwise Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

48.89

18.84

-108.93

49.57

-157.63

China Healthwise Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-411.76	-134.04	72.41	-100.00	-166.67

China Healthwise Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

China Healthwise Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.152	-	-0.059)	/	\| -0.059 \|
=	-157.63 %

China Healthwise Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.128	-	-0.048)	/	\| -0.048 \|
=	-166.67 %

China Healthwise Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

China Healthwise Holdings (HKSE:00348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG

Website

http://www.healthwisehk.com/en

China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.

Executives

Eternity Investment Limited	2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited	2201 Interest of corporation controlled by you
Heng Tai Finance Limited	2101 Beneficial owner
Lei Hong Wai	2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines